byiShook Opinion
Sep 9, 2024 - 09:00
Summit shares jumped Monday after positive late-stage indications vs. Merck's Keytruda. The post Biotech Stocks: Lung Cancer Treatment Outflanks Merck's Keytruda appeared first on Investor's Business Daily.
Summit shares jumped Monday after positive late-stage indications vs. Merck's Keytruda.
The post Biotech Stocks: Lung Cancer Treatment Outflanks Merck's Keytruda appeared first on Investor's Business Daily.